Week in Brief

Insurance: CMS and the Department of the Treasury Issue New Guidance on Section 1332 State Waivers for Private Health Insurance Coverage.

  • Statement from Senate HELP Committee Chairman Lamar Alexander (R-TN)
  • Statement from Senate HELP Committee Ranking Member Patty Murray (D-WA)
  • Statement from Senate Finance Committee Ranking Member Ron Wyden (D-OR)
  • Statement from Energy and Commerce Ranking Member Frank Pallone (D-NJ), Ways and Means Ranking Member Richard Neal (D-MA), and Education and the Workforce Ranking Member Bobby Scott (D-VA)
  • Guidance for State Waivers

Insurance: The Department of the Treasury, HHS, and the Department of Labor Issue a Proposal on the Expansion of Health Reimbursement Arrangements (HRA).

Opioids: President Donald Trump Signs Opioid Legislation Package into Law.

  • Statement from President Donald Trump
  • Statement form Senate HELP Committee Chairman Lamar Alexander (R-TN)
  • Statement from Senate HELP Committee Ranking Member Patty Murray (D-WA)
  • Statement from Senate Judiciary Committee Chairman Chuck Grassley (R-IA), Senator John Cornyn (R-TX), House Oversight and Government Reform Committee Chairman Trey Gowdy (R-SC), and Subcommittee Chairman Mark Meadows (R-NC)
  • Statement form House Energy and Commerce Chairman Greg Walden (R-OR) and Subcommittee on Health Chairman Michael Burgess (R-TX)
  • Statement from House Energy and Commerce Ranking Member Frank Pallone (D-NJ)
  • Statement from House Judiciary Committee Chairman Bob Goodlatte (R-VA)
  • Statement from House Ways and Means Committee Chairman Kevin Brady (R-TX)
  • Statement from FDA Commissioner Scott Gottlieb
  • Statement from White House Office of National Drug Control Policy (ONDCP) Deputy Director James Carroll
  • Fact Sheet on Administration’s Initiatives to Combat the Opioid Crisis
  • List of Private-Sector and Non-Profit Partners Working to Combat the Opioid Crisis

WHITE HOUSE

Opioids: The White House Office of National Drug Control Policy (ONDCP) Releases “The Truth About Opioids” Drug Prevention Ads.


LEGISLATIVE UPDATE

Monday, October 22

Medicare and Medicaid:  Senate Finance Committee Ranking Member Ron Wyden (D-OR) Comments on Proposed Changes to Medicare, Medicaid, and Social Security.

Tuesday, October 23

Opioids: Senate HELP Committee Ranking Member Patty Murray (D-WA) and Senator Elizabeth Warren (D-MA) Issue Statements on Recent GAO Report Detailing Public Health Emergency Authorities in the Opioid Crisis.

  • Report from the GAO on the Status of Public Health Emergency Authorities

Children’s Health: Senate Finance Committee Chairman Orrin Hatch (R-UT) Remarks on the Extension and Passage of Legislation Surrounding Children’s Health.

Wednesday, October 24

Prescriptions: Senate Finance Committee Chairman Orrin Hatch (R-UT) Seeks Information to Prevent the Sale of Counterfeit Drugs Online.

Insurance: House Oversight and Government Reform Committee Ranking Member Elijah Cummings (D-MD) ReleasesReport on the Administration’s Decision to Not Defend Federal Protections for Preexisting Conditions.

Thursday, October 25

Opioids:  House Energy and Commerce Committee Chairman Greg Walden (R-OR) and Subcommittee on Oversight and Investigations Chairman Gregg Harper (R-MS) Release Statement on New Opioid Strike Force.


REGULATORY UPDATE

Monday, October 22

Substance Abuse: FDA Commissioner Scott Gottlieb Discusses Ongoing Commitment to Tobacco and Nicotine Regulations.

Mental Health: NIH Study Demonstrates Ineffectiveness of Antipsychotics in the Treatment of Intensive Care Patients with Delirium.

Tuesday, October 23

Opioids: The GAO Reviews HHS Decision to Declare the Opioid Crisis a Public Health Emergency.

Opioids: FDA Commissioner Scott Gottlieb Announces Meeting Regarding Access to Naloxone to Counter the Effects of Opioids.

Opioids: FDA Launches International Crackdown on Websites Selling Illegal Drugs, Including Opioids.

Opioids: CMS Announces Maternal Opioid Misuse (MOM) Model.

Thursday, October 25

Prescription Pricing: HHS and CMS Proposes New International Drug Pricing Index.

  • Statement from President Donald Trump
  • Statement from Senate Finance Committee Ranking Member Ron Wyden (D-OR)
  • Statement from House Committee on Energy and Commerce Chairman Greg Walden (R-OR) and House Committee on Ways and Means Chairman Kevin Brady (R-TX)
  • Statement from  Energy and Commerce Ranking Member Frank Pallone (D-NJ)
  • Statement from House Committee on Oversight and Government Reform Ranking Member Elijah Cummings (D-MD)
  • Fact Sheet from the White House
  • Fact Sheet from CMS

Opioids: HHS’s Office of Civil Rights (OCR) Launches Campaign to Increase Non-Discrimination in Access to Treatment and Recovery Services.


EVENTS

National Institute of Health
Director’s Seminar Series: Blood-Based Biomarkers that Shape Recovery from Traumatic Brain Injuries.
November 16, 12:00-1:00 PM
Building 1, Wilson Hall

Senate HELP Committee
Full Committee Hearing: Reducing Health Care Costs: Improving Affordability through Innovation.
November 28, 2018 10:00 AM
430 Dirksen Senate Office Building